Articles
NANS and Partner Societies Urge Carelon to Reconsider Restrictive SCS Policy
The North American Neuromodulation Society (NANS), alongside several leading medical societies, has submitted a formal letter to Carelon Medical Benefits Management in response to its recent policy denying coverage for spinal cord stimulation (SCS) in patients with non-surgical low back pain.
Humana Imposes Further Restrictions on Medicare Coverage for Neuromodulation Therapies
Open enrollment for Medicare Advantage runs October 15 – December 7. Physicians should be aware that Humana’s Medicare Advantage plan has some of the most rigorous and strict prior authorization requirements for neuromodulation therapies like spinal cord stimulation (SCS) and peripheral nerve stimulation (PNS).
NANS Comments on CMS CY 2025 Proposed Rule Making
The North American Neuromodulation Society (NANS) crafted a letter in response to the CMS Proposed Rule Making on revisions to Medicare payment policies under the Physician Payment Schedule (PFS) for calendar year (CY) 2025.
NANS Leads Response to Washington State’s Draft Guidelines for SCS Coverage
On behalf of the 40,000+ members across 10 medical societies, NANS submitted a response to draft guidelines for SCS coverage proposed by the Washington State Health Technology Clinical Committee.
Washington State Approves Coverage for Spinal Cord Stimulation, Granting Access to Care for Millions of Residents
On May 17, in a follow-up meeting with the Washington State Health Technology Clinical Committee (HTCC), members voted to cover spinal cord stimulation (SCS) for patients with nonsurgical low back pain, diabetic peripheral neuropathy and failed back surgery syndrome.
Washington State poised to extend coverage for SCS
NANS led advocacy efforts on behalf of 13 medical societies to extend coverage for SCS in Washington State. The State’s Health Technology Clinical Committee met to hear from stakeholders on the issue.